155 related articles for article (PubMed ID: 25525980)
1. Determination of the severity of ureteropelvic junction obstruction using urinary epidermal growth factor and kidney injury molecule 1 levels.
Mohammadjafari H; Rafiei A; Kosaryan M; Yeganeh Y; Hosseinimehr SJ
Biomark Med; 2014; 8(10):1199-206. PubMed ID: 25525980
[TBL] [Abstract][Full Text] [Related]
2. Urinary carbohydrate antigen 19-9/creatinine ratio: A non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children.
Alizadeh F; Taefnia AM; Haghdani S
J Pediatr Urol; 2018 Feb; 14(1):62.e1-62.e4. PubMed ID: 29079483
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the outcome of antenatal hydronephrosis: significance of urinary EGF.
Li Z; Zhao Z; Liu X; Su Z; Shang X; Wen J
Pediatr Nephrol; 2012 Dec; 27(12):2251-9. PubMed ID: 22773267
[TBL] [Abstract][Full Text] [Related]
4. Role of urinary levels of endothelin-1, monocyte chemotactic peptide-1, and N-acetyl glucosaminidase in predicting the severity of obstruction in hydronephrotic neonates.
Mohammadjafari H; Rafiei A; Mousavi SA; Alaee A; Yeganeh Y
Korean J Urol; 2014 Oct; 55(10):670-6. PubMed ID: 25324951
[TBL] [Abstract][Full Text] [Related]
5. Proximal tubule proteins are significantly elevated in bladder urine of patients with ureteropelvic junction obstruction and may represent novel biomarkers: A pilot study.
Gerber C; Harel M; Lynch ML; Herbst KW; Ferrer FA; Shapiro LH
J Pediatr Urol; 2016 Apr; 12(2):120.e1-7. PubMed ID: 26705690
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor and monocyte chemotactic peptide-1: potential biomarkers of urinary tract obstruction in children with hydronephrosis.
Madsen MG; Nørregaard R; Palmfeldt J; Olsen LH; Frøkiær J; Jørgensen TM
J Pediatr Urol; 2013 Dec; 9(6 Pt A):838-45. PubMed ID: 23228281
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic performance of urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin for acute kidney injury in an obstructive nephropathy patient.
Xue W; Xie Y; Wang Q; Xu W; Mou S; Ni Z
Nephrology (Carlton); 2014 Apr; 19(4):186-94. PubMed ID: 24165570
[TBL] [Abstract][Full Text] [Related]
8. KIM-1 Is a Potential Urinary Biomarker of Obstruction: Results from a Prospective Cohort Study.
Olvera-Posada D; Dayarathna T; Dion M; Alenezi H; Sener A; Denstedt JD; Pautler SE; Razvi H
J Endourol; 2017 Feb; 31(2):111-118. PubMed ID: 27852120
[TBL] [Abstract][Full Text] [Related]
9. Urinary biomarkers in hydronephrosis.
Madsen MG
Dan Med J; 2013 Feb; 60(2):B4582. PubMed ID: 23461995
[TBL] [Abstract][Full Text] [Related]
10. Is it Always Necessary to Treat an Asymptomatic Hydronephrosis Due to Ureteropelvic Junction Obstruction?
Sarin YK
Indian J Pediatr; 2017 Jul; 84(7):531-539. PubMed ID: 28466405
[TBL] [Abstract][Full Text] [Related]
11. Urinary angiotensinogen as a novel marker of obstructive nephropathy in children.
Taranta-Janusz K; Wasilewska A; Dębek W; Fiłonowicz R; Michaluk-Skutnik J
Acta Paediatr; 2013 Sep; 102(9):e429-33. PubMed ID: 23772991
[TBL] [Abstract][Full Text] [Related]
12. [Upper urinary tract tumor and hydronephrosis to pelviureteric junction obstruction: a rare association].
Ennaciri S; Omana JP
Pan Afr Med J; 2018; 31():201. PubMed ID: 31447962
[TBL] [Abstract][Full Text] [Related]
13. Urinary cytokine profiles in unilateral congenital hydronephrosis.
Taranta-Janusz K; Wasilewska A; Dębek W; Waszkiewicz-Stojda M
Pediatr Nephrol; 2012 Nov; 27(11):2107-2113. PubMed ID: 22744767
[TBL] [Abstract][Full Text] [Related]
14. The roles of serum and urinary carbohydrate antigen 19-9 in the management of patients with antenatal hydronephrosis.
Atar A; Oktar T; Kucukgergin C; Kalelioglu I; Seckin S; Ander H; Ziylan O; Kadioglu TC
J Pediatr Urol; 2015 Jun; 11(3):133.e1-5. PubMed ID: 25824879
[TBL] [Abstract][Full Text] [Related]
15. The role of urinary NGAL and serum cystatin C in assessing the severity of ureteropelvic junction obstruction in infants.
Pavlaki A; Printza N; Farmaki E; Stabouli S; Taparkou A; Sterpi M; Dotis J; Papachristou F
Pediatr Nephrol; 2020 Jan; 35(1):163-170. PubMed ID: 31606750
[TBL] [Abstract][Full Text] [Related]
16. Urinary polyomavirus: novel biomarker of congenital ureteropelvic junction obstruction.
Assadi F; Mazaheri M
J Pediatr Urol; 2020 Feb; 16(1):107.e1-107.e5. PubMed ID: 31818677
[TBL] [Abstract][Full Text] [Related]
17. Is urine intercellular adhesion molecule-1 a marker of renal disorder in children with ureteropelvic junction obstruction?
Taranta-Janusz K; Wasilewska A; Roszkowska R; Michaluk-Skutnik J
Biomarkers; 2016; 21(2):123-8. PubMed ID: 26631256
[TBL] [Abstract][Full Text] [Related]
18. Semaphorin-3A and Netrin-1 predict the development of kidney injury in children with congenital hydronephrosis.
Li X; Liu X; Li J; Song E; Sun N; Liu W; Wang T; Yang J; Li Z
Scand J Clin Lab Invest; 2018; 78(1-2):55-61. PubMed ID: 29199452
[TBL] [Abstract][Full Text] [Related]
19. Urinary kidney injury molecule-1: a novel biomarker to monitor renal function in patients with unilateral ureteral obstruction.
Qian S; Xia W; Wu Y; Cao Q; Ding Y; Huang Y; Shen H
Int Urol Nephrol; 2020 Nov; 52(11):2065-2072. PubMed ID: 32507943
[TBL] [Abstract][Full Text] [Related]
20. Urinary Emmprin, matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 as potential biomarkers in children with ureteropelvic junction narrowing on conservative treatment.
Tian F; Gu C; Zhao Z; Li L; Lu S; Li Z
Nephrology (Carlton); 2015 Mar; 20(3):194-200. PubMed ID: 25470073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
